Back to Search
Start Over
Bayer: kidney cancer drug offers hope for patients and pipeline.
- Source :
- PharmaWatch: Monthly Review; December2004, Vol. 3 Issue 12, p6-6, 2/3p
- Publication Year :
- 2004
-
Abstract
- Reports that Bayer AG and Onyx Pharmaceuticals Inc. have announced positive study data for the Bay 43-9006 drug in the treatment of kidney cancer. Evidence of antitumor activity; Goal of obtaining approval for the drug; Observations noted from patients enrolled in the study.
Details
- Language :
- English
- Volume :
- 3
- Issue :
- 12
- Database :
- Complementary Index
- Journal :
- PharmaWatch: Monthly Review
- Publication Type :
- Report
- Accession number :
- 17642988